×
The central target of $7 is the arithmetic mean of three verified analyst price targets, rounded from roughly $6.83. The three analyst targets span a wide range of about $4.50 to $10, reflecting sharply different views on the acquisition-driven growth story.
Net sales climbed 225% year over year to $42.0 million, marking the first full quarter with Navitas Organics and Terrasoul Superfoods operating under one platform. Net income under generally accepted accounting principles (GAAP) swung to $1.7 million, or $0.03 per share, from a $1.0 million loss a year earlier.
The central stock price target of $10.50 is the arithmetic mean of four verified analyst price targets, which range from a low of $5 to a high of $15. With BioHarvest Sciences shares recently trading near $1.63, reaching $10.50 would require a rise of roughly 545% — a very large move by any measure.
The central target of $32 is the arithmetic mean of three verified analyst price targets, rounded from an underlying average of roughly $32.33. The individual analyst targets span an approximate range of $30 to $35 , with a consensus rating of Strong Buy.
Lifeway Foods reported record quarterly net sales of $67.8 million for the third quarter of 2026, up 18.6% year over year and marking its 28th consecutive quarter of year-over-year sales growth. Earnings per share (EPS) came in at $0.02 , below the consensus estimate of $0.06 , as higher input costs weighed on profitability.
The central target of $16 is the rounded average analyst price target for OFRM , with the underlying mean near $16.17 across roughly ten analyst estimates. With the stock trading around $10, reaching $16 implies a roughly 59% gain, a very large move from current levels.
The central price target of $28.50 is the arithmetic mean of two verified analyst price targets: Canaccord Genuity's $17 and Cantor Fitzgerald's $40. With shares recently near $7 to $8, reaching $28.50 implies roughly 250% to 300% upside, a very large required move.
The $7.00 central target is a fallback objective derived from public discussion, not an analyst consensus; it reflects a round psychological level near the stock's 200-day moving average. It was chosen because the latest verified analyst price targets ($5.00 to $6.00) sit at or below the current share price, leaving no usable upside aggregate.
Net sales fell 4.7% year over year to $1.169 billion, roughly in line with Wall Street's consensus estimate. Adjusted earnings per share (EPS) of $0.10 missed the consensus estimate of $0.15 by about 34%.
Return to profitability remains the central catalyst. Management has guided for a net loss in the current period but is positioning the business around cost control, capacity utilization, and new product launches as the pathway to improved results. Capacity expansion sets up operating leverage. Production capacity has grown by more than 40% since fiscal 2023, creating room to scale revenue as utilization improves from currently low levels.
NAII is Natural Alternatives International, Inc., a U.S.-based formulator, manufacturer, and marketer of nutritional supplements, founded in 1980 and headquartered in Carlsbad, California. The company operates through two reportable segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing .
Retail and private-label momentum: Expanding shelf placement with major club and grocery retailers, alongside a growing private-label pipeline, represents a core growth catalyst for the company's branded and white-label product lines. Proprietary technology edge: BranchOut's exclusive license to EnWave Corporation's GentleDry dehydration technology supports differentiated taste, texture, and nutrient retention that underpins its market positioning.
BranchOut Food Inc. ( BOF ) is a U.S.-listed, growth-stage consumer packaged foods company focused on plant-based, dehydrated fruit and vegetable snacks and powders. The company manufactures its products at a leased 50,000-square-foot facility in Pisco, Peru, using a proprietary dehydration platform called GentleDry™ Technology.
Farmmi, Inc. (FAMI) has drifted roughly 6% lower over the trailing month, consolidating near the $0.10 level. The stock remains a thinly traded micro-cap prone to sharp, episodic swings in price and trading volume.
Both CPB and GIS are consumer staples names facing soft demand, input-cost inflation, and share losses, but their trajectories have recently diverged. Tickeron AI Verdict: GIS is the favored ticker of the two, reflecting a steadier dividend record, improving sales trajectory, and stronger near-term earnings momentum relative to CPB.
Tickeron AI Verdict: KHC. Kraft Heinz's more consistent trend, maintained dividend, and beat-and-raise quarter give it the edge over Conagra Brands in the current environment. Both stocks are mature packaged-food companies facing volume declines, cost inflation, and private-label competition, but their relative positioning has diverged meaningfully.
The central price target of $1.50 represents roughly 50% upside from the latest price near $1.00. This target is not an analyst consensus. NAII has no credible sell-side dollar price targets, so $1.50 is a fallback objective drawn from public technical discussion.
The $6.00 figure reflects a single published analyst price target — Lake Street's Buy rating with a $6 target issued August 3, 2026 — rather than a genuine Wall Street consensus, which does not meaningfully exist for this micro-cap. With BranchOut Food Inc. (BOF) shares near $1.66, reaching $6.00 would require a roughly 261% advance, an extremely large move by any standard.
USANA Health Sciences (USNA) edged up +0.46% during regular market hours, moving from a previous close of $13.10 to $13.16. No verified news or fundamental catalyst found. The move is consistent with routine, low-volatility consolidation after the prior session's -5.42% decline and the post-earnings selloff that followed disappointing Q3 results.
Seneca Foods (SENEB) fell from a prior close of $168.05 to $154.61, down -8.00%, during Wednesday's regular session. No verified news or fundamental catalyst found; the decline likely reflects thin order-book liquidity in this thinly traded Class B share, whose typical daily move is only about 2%.